United States
  • Europe
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health

Categories

  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Chicago
  • Computing
  • Dallas
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Fort Worth
  • Gadgets
  • Genetics
  • Golf
  • Health
  • Health care
  • Houston
  • Internet
  • Jacksonville
  • Jobs
  • Los Angeles
  • Markets
  • Medication
  • Mental health
  • MLB
  • Mobile
  • Movies
  • Music
  • NASCAR
  • NBA
  • NCAA Basketball
  • NCAA Football
  • New York
  • News
  • NFL
  • NHL
  • Nutrition
  • Personal finance
  • Philadelphia
  • Phoenix
  • Physics
  • San Antonio
  • San Diego
  • Science
  • Soccer
  • Space
  • Sports
  • Technology
  • Tennis
  • TV
  • United States
  • US
  • Virtual reality
  • Wildlife
  • WNBA
  • World
United States
  • Europe
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health

Browsing Tag

Diseases of the nervous system

3 posts
GGenetics
MYH2-associated myopathy caused by novel compound heterozygous mutations: a case report and literature review
Read More

MYH2-associated myopathy caused by novel compound heterozygous mutations: a case report and literature review

  • September 1, 2025
Morales PN, Coons AN, Koopman AJ, Patel S, Chase PB, Parvatiyar MS, et al. Post-translational modifications of vertebrate…
GGenetics
Machine learning in Alzheimer’s disease genetics
Read More

Machine learning in Alzheimer’s disease genetics

  • July 22, 2025
School of Medicine, Cardiff University, Cardiff, UK Matthew Bracher-Smith, Julie Williams, Nicola Denning, Alun Meggy & Valentina Escott-Price Centre for Neuropsychiatric Genetics and…
GGenetics
AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial
Read More

AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial

  • June 27, 2025
Study design and oversight This ongoing, nonrandomized, open-label, ascending-dose, phase 1b study (ClinicalTrials.gov registration no. NCT03362502) was initiated…
United States
www.europesays.com